Pfizer Inc. (LON:0Q1N)

Market Cap	115.47B
Revenue (ttm)	46.55B
Net Income (ttm)	7.84B
Shares Out	n/a
EPS (ttm)	1.38
PE Ratio	14.73
Forward PE	9.93
Dividend	1.31 (4.78%)
Ex-Dividend Date	Jul 25, 2025

Volume	275,979
Average Volume	180,683
Open	27.12
Previous Close	26.98
Day's Range	27.04 - 27.69
52-Week Range	20.77 - 30.41
Beta	0.46
RSI	72.81
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Pharmaceutical Preparations
• Founded: 1849
• Employees: 81,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q1N

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD